Northern Trust
ETON icon

Northern Trust’s Eton Pharmaceutcials ETON Stock Holding History

Northern Trust’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.26M Buy
255,849
+18,017
+8% +$528K ﹤0.01% 2261
2026
Q1 		$5.87M Buy
237,832
+5,983
+3% +$105K ﹤0.01% 2373
2025
Q4 		$3.92M Sell
231,849
-13,202
-5% -$232K ﹤0.01% 2612
2025
Q3 		$5.32M Sell
245,051
-17,160
-7% -$285K ﹤0.01% 2463
2025
Q2 		$3.74M Buy
262,211
+177,761
+210% +$2.81M ﹤0.01% 2634
2025
Q1 		$1.1M Sell
84,450
-2,507
-3% -$37.9K ﹤0.01% 3240
2024
Q4 		$1.16M Buy
86,957
+22,827
+36% +$231K ﹤0.01% 3328
2024
Q3 		$385K Buy
64,130
+4,281
+7% +$18.1K ﹤0.01% 3656
2024
Q2 		$197K Sell
59,849
-1,281
-2% -$4.48K ﹤0.01% 3873
2024
Q1 		$229K Sell
61,130
-3,460
-5% -$15.1K ﹤0.01% 3852
2023
Q4 		$283K Buy
64,590
+27,083
+72% +$109K ﹤0.01% 3751
2023
Q3 		$156K Buy
37,507
+4,564
+14% +$17.6K ﹤0.01% 3897
2023
Q2 		$115K Sell
32,943
-147
-0.4% -$541 ﹤0.01% 3998
2023
Q1 		$127K Buy
33,090
+2,735
+9% +$9.97K ﹤0.01% 4018
2022
Q4 		$85.6K Hold
30,355
– – ﹤0.01% 4143
2022
Q3 		$64K Hold
30,355
– – ﹤0.01% 4255
2022
Q2 		$80K Hold
30,355
– – ﹤0.01% 4259
2022
Q1 		$132K Hold
30,355
– – ﹤0.01% 4261
2021
Q4 		$130K Hold
30,355
– – ﹤0.01% 4343
2021
Q3 		$153K Hold
30,355
– – ﹤0.01% 4270
2021
Q2 		$187K Sell
30,355
-147,603
-83% -$1.09M ﹤0.01% 4182
2021
Q1 		$1.3M Sell
177,958
-5,668
-3% -$48.4K ﹤0.01% 3471
2020
Q4 		$1.49M Buy
183,626
+17,948
+11% +$138K ﹤0.01% 3339
2020
Q3 		$1.31M Buy
165,678
+110,238
+199% +$753K ﹤0.01% 3263
2020
Q2 		$302K Buy
55,440
+34,047
+159% +$169K ﹤0.01% 3660
2020
Q1 		$88K Hold
21,393
– – ﹤0.01% 3847
2019
Q4 		$154K Hold
21,393
– – ﹤0.01% 3853
2019
Q3 		$135K Buy
+21,393
New +$137K ﹤0.01% 3857

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Northern Trust's ETON Position: Q2 2026 in Review

Northern Trust increased its Eton Pharmaceutcials (ETON) stake by 7.6% in Q2 2026, buying an estimated $528K and bringing the position to 255,849 shares worth $9.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

Northern Trust first reported a position in ETON in Q3 2019 and has held it in 28 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Northern Trust held 255,849 shares of Eton Pharmaceutcials worth $9.26M as of Q2 2026.
  • Northern Trust bought 18,017 Eton Pharmaceutcials shares in Q2 2026, an estimated $528K.
  • Eton Pharmaceutcials made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2261 holding.
  • Northern Trust first reported a position in Eton Pharmaceutcials in Q3 2019 and has held it in 28 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.